Multiple Introductions of Salmonella enterica Serovar Typhi H58 with Reduced Fluoroquinolone Susceptibility into Chile.
Emerg Infect Dis
; 26(11): 2736-2740, 2020 11.
Article
en En
| MEDLINE
| ID: mdl-33079054
ABSTRACT
Salmonella enterica serovar Typhi H58, an antimicrobial-resistant lineage, is globally disseminated but has not been reported in Latin America. Genomic analysis revealed 3 independent introductions of Salmonella Typhi H58 with reduced fluoroquinolone susceptibility into Chile. Our findings highlight the utility of enhanced genomic surveillance for typhoid fever in this region.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Salmonella typhi
/
Fiebre Tifoidea
/
Fluoroquinolonas
/
Farmacorresistencia Bacteriana
/
Antibacterianos
Límite:
Humans
País/Región como asunto:
America do sul
/
Chile
Idioma:
En
Revista:
Emerg Infect Dis
Asunto de la revista:
DOENCAS TRANSMISSIVEIS
Año:
2020
Tipo del documento:
Article